IDH2 and acute myeloid leukemia: Numerous studies have shown that IDH1/IDH2 mutations frequently occur in low-grade gliomas7, secondary glioblastoma8, chondrosarcoma9, acute myeloid leukemia (AML)10, and intrahepatic cholangiocarcinoma11.